Dr. Paul Richardson commented on the US Food and Drug Administration’s decision to expand the existing indication for lenalidomide (Revlimid) in combination with dexamethasone to include patients with newly diagnosed multiple myeloma.
Former “NBC Nightly News” anchor Tom Brokaw, who was diagnosed with multiple myeloma in 2013, toured Dana-Farber and spoke at the Visiting Committee dinner.
Dr. Paul Richardson led a study showing treatment with an investigational oral drug led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.
Tags: chemotherapy, MultipleMyeloma
Tags: BasicResearch, MultipleMyeloma
Tags: MultipleMyeloma, Leukemia
Tags: Genomics, MultipleMyeloma
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: